Clindamycin Phosphate 1% Topical Gel from Japan
Topical gel containing 1% clindamycin phosphate for treating acne vulgaris by inhibiting bacterial growth on the skin. This retail-packaged product is classified in HTS 3004.20.00.55 due to its clindamycin salt content in measured doses.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Label with full ingredient disclosure and acne treatment claims per FDA OTC or Rx rules
• Test for microbial contamination common in topical imports; include lab certificates
• Avoid retail packaging that mimics cosmetics to prevent misclassification